MARKET

WST

WST

West Pharm Svcs
NYSE
368.18
-17.55
-4.55%
After Hours: 368.18 0 0.00% 16:20 04/25 EDT
OPEN
384.48
PREV CLOSE
385.73
HIGH
390.33
LOW
364.89
VOLUME
742.38K
TURNOVER
0
52 WEEK HIGH
415.73
52 WEEK LOW
309.90
MARKET CAP
26.95B
P/E (TTM)
46.72
1D
5D
1M
3M
1Y
5Y
WEST PHARMACEUTICAL SERVICES INC <WST.N>: JEFFERIES RAISES TARGET PRICE TO $426 FROM $423
Reuters · 1h ago
BUZZ-U.S. STOCKS ON THE MOVE-Loar, Regeneron, Intel
U.S. Stocks slumped on Thursday. Dow Jones Industrial Average was down 1.15% and the S&P 500 was down 0.76%. Most megacaps fell after Meta Platforms' quarterly results. Newmont Corp. Was the top percentage gainer on the NYSE and the Nasdaq.
Reuters · 13h ago
BUZZ-U.S. STOCKS ON THE MOVE-Viking, Alphabet, Dover
U.S. Stocks were sharply lower on Thursday. The Dow Jones Industrial Average was down 1.58% and the S&P 500 and Nasdaq Composite were also down. Meta Platforms dropped 12.7% after dour quarterly results. Newmont Corp was the top percentage gainer on the S.P. 500 and the Nasdaq.
Reuters · 14h ago
WST Stock Earnings: West Pharmaceutical Servs Beats EPS, Beats Revenue for Q1 2024
West Pharmaceutical Servs reported earnings per share of $1.56 for the first quarter of 2024. The company reported revenue of $695.40 million. This was 3.74% better than the analyst estimate for the same period. West pharmaceutical Servs just reported results.
Investorplace · 16h ago
BUZZ-West Pharmaceutical falls after Q1 revenue declines
West Pharmaceutical's WST.N shares fall 1.3% to $380.64. Company reports Q1 revenue of $695.4 mln vs $716.6 mln a year earlier. Revenue from WST's proprietary products unit fell 4%. Company raises 2024 profit forecast.
Reuters · 16h ago
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
NASDAQ · 16h ago
West Pharmaceutical Services Inc reports results for the quarter ended in March - Earnings Summary
West Pharmaceutical Services Inc reports quarterly adjusted earnings of $1.56 per share for the quarter ended in March. Revenue fell 3% to $695.40 million from the same quarter last year. The company reported quarterly income of $115.3 million. West Pharmaceutical Services shares have fallen 2.5% this quarter.
Reuters · 17h ago
West Pharmaceutical Services Unveils Latest Financial Results
TipRanks · 19h ago
More
About WST
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Webull offers West Pharmaceutical Services Inc. stock information, including NYSE: WST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WST stock methods without spending real money on the virtual paper trading platform.